Physician profile
Natalie E Borg
NPI 1841447364
$1,608.90
in general payments reported to CMS, 2019-2025
16 companies · $289 in 2025
The $289 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.32 · 2020: $60.10 · 2021: $127 · 2022: $279 · 2023: $521 · 2024: $262 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,071.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,071.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $423.62 | 2021-2025 | Qulipta, Vraylar, Ubrelvy |
| Novo Nordisk INC | $411.64 | 2019-2024 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $212.01 | 2019-2025 | |
| Glaxosmithkline, LLC. | $154.95 | 2021-2025 | Shingrix, Arexvy, Bexsero |
| Exact Sciences Corporation | $141.37 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amgen INC. | $49.74 | 2022-2025 | Evenity |
| Janssen Pharmaceuticals, INC | $49.14 | 2019-2022 | |
| Horizon Therapeutics Plc | $35.33 | 2019-2020 | |
| Boston Scientific Corporation | $21.85 | 2025 | Wavewriter Alpha Prime 16 |
| Astellas Pharma US INC | $20.39 | 2024 | Veozah |
| Abbott Laboratories | $19.28 | 2023 | Proclaim |
| Lilly USA, LLC | $16.84 | 2024 | Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.87 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $13.88 | 2024 | Airsupra |
| Novartis Pharmaceuticals Corporation | $12.79 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $11.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Borg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.